Vanta Clinical Research Limited, a active public limited company, was established on 12 September 2018 in Secunderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100TG2018PLC126673. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
Its leadership includes Dopesh Raja Mulakala (Director), Mulakala Sajan Kiran (Director), Chintapatla Shravan (Director). Past directors included Sailendrakumar Jagabandhu Goswami, Mulakala Sajan Kiran, Chintapatla Shravan. It holds ₹30.01 Cr open charges and ₹17.00 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at No.02/G/308/G, No.3/Ff/Sf/1-20-248, Umajay Complex, Rasoolpura, Secunderabad, Telangana, 500003.
U73100TG2018PLC126673
126673
12 September 2018
₹3.00 Cr
₹3.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vanta Clinical Research Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dopesh Raja Mulakala | Director | 12 Sep 2018 | Current |
| Mulakala Sajan Kiran | Director | 07 Mar 2020 | Current |
| Chintapatla Shravan | Director | 18 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 20 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vanta Clinical Research Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 99.56% decrease. The company also saw a substantial fall in profitability, with a 1261.53% decrease in profit. The company's net worth dipped by a decrease of 0.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Vanta Clinical Research had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹300,053,753.00
₹170,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | Others | ₹19.97 Cr | Open |
| 01 Jul 2020 | State Bank Of India | ₹10.04 Cr | Open |
| 03 Dec 2019 | Axis Bank Limited | ₹17.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vanta Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vanta Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanta Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with State Bank Of India of Rs. 10.04 Cr registered on 01 Jul 2020 with Charge ID 100353753 was modified on 25 Mar 2025. was completed.
The activity A charge registered on 03 Dec 2019 via Charge ID 100311512 with Axis Bank Limited was fully satisfied on 26 Sep 2023. was completed.
A charge with Others amounted to Rs. 19.97 Cr with Charge ID 100595387 was registered on 28 Jun 2022. was recorded as a recent event.
The activity Vanta Clinical Research Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Vanta Clinical Research Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was recorded as a recent event.
Chintapatla Shravan was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
The CIN of Vanta Clinical Research Limited is U73100TG2018PLC126673.
Vanta Clinical Research Limited is headquartered at No.02/G/308/G, No.3/Ff/Sf/1-20-248, Umajay Complex, Rasoolpura, Secunderabad, Telangana, 500003.
Vanta Clinical Research Limited was incorporated on 12 September 2018.
The current directors of Vanta Clinical Research Limited are
The primary industry of Vanta Clinical Research Limited is Professional, Scientific And Technical.
Vanta Clinical Research Limited is unlisted.
The authorized capital of Vanta Clinical Research Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX